Jane Street’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Jane Street’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,666	Closed	-$1.32M	–	6140
2019 Q3	$1.32M	Buy	+13,666	New	+$1.37M	﹤0.01%	2265
2019 Q1	–	Sell	-9,665	Closed	-$710K	–	5984
2018 Q4	$378K	Buy	+9,665	New	+$419K	﹤0.01%	3794
2018 Q2	–	Sell	-23,621	Closed	-$1.57M	–	5936
2018 Q1	$1.57M	Buy	+23,621	New	+$1.36M	﹤0.01%	2125
2016 Q2	–	Sell	-8,125	Closed	-$240K	–	4834
2016 Q1	$240K	Sell	8,125 -1,512	-16%	-$47.7K	﹤0.01%	3486
2015 Q4	$437K	Sell	9,637 -5,716	-37%	-$300K	﹤0.01%	2646
2015 Q3	$641K	Buy	+15,353	New	+$801K	﹤0.01%	2050
2015 Q2	–	Sell	-8,379	Closed	-$649K	–	4243
2015 Q1	$649K	Buy	+8,379	New	+$483K	0.01%	1779

Jane Street's ONCE Position: Q4 2019 in Review

Jane Street sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 13,666 shares — an estimated $1.32M sold.

Jane Street first reported a position in ONCE in Q1 2015 and held it in 7 quarters. The position peaked at $1.57M in Q1 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Jane Street reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Jane Street sold 13,666 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.32M.
Jane Street first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
Jane Street's Spark Therapeutics, Inc. Common Stock position peaked at $1.57M in Q1 2018.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.